Dr. Joerg Moeller
Appointment to the Board
January 2024.
Experience and expertise
Before joining BenevolentAI, Joerg served as executive vice president, head of global research and development and member of the global leadership team of LEO Pharma. He re-organised and re-structured the global research and development organisation to support growth and innovation ambitions of the company.
Prior to LEO Pharma, Joerg was at Bayer AG for over 20 years where he held various executive roles culminating in his appointment as executive vice president, head of pharmaceuticals research and development and member of the executive committee of the pharmaceuticals division of Bayer AG. During his time at Bayer he successfully managed development and global product approvals, redefined Bayer’s pipeline strategy and initiated several drug discovery collaborations with AI platform companies and is a strong advocate of this strategy.
Joerg graduated as a Doctor of Medicine and holds a PhD from Ruhr University Bochum, Germany.
Current external appointments
Joerg currently serves on the board of Secura Bio, a privately held US biotech company.